Jade Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-3.6M | — |
| FY2020 | — | $-13.3M | $4.6M |
| FY2021 | — | $172.4M | $54.2M |
| FY2022 | — | $126.7M | $22.4M |
| FY2023 | — | $109.5M | $23.5M |
| FY2024 | — | $1.0K | $69.4M |
| FY2025 | — | $332.5M | $88.4M |